United States · FDA National Drug Code directory
Losartan Potassium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-7368_3fa33b06-383d-42a5-9349-35d3bdf9ab30
- Product NDC
- 0093-7368
- Form
- TABLET, FILM COATED
- Composition / generic term
- Losartan Potassium and Hydrochlorothiazide
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100406
- Source listing expiry
- 20271231
Source-listed ingredients
- LOSARTAN POTASSIUM — 100 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (0093-7368-10) · 0093-7368-10
- 30 TABLET, FILM COATED in 1 BOTTLE (0093-7368-56) · 0093-7368-56
- 90 TABLET, FILM COATED in 1 BOTTLE (0093-7368-98) · 0093-7368-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →